ALLIANCEBERNSTEIN L.P. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$618,734
-27.9%
25,4100.0%0.00%
Q1 2024$858,096
+7.1%
25,4100.0%0.00%
Q4 2023$801,177
+23.4%
25,4100.0%0.00%
Q3 2023$649,226
-72.1%
25,410
-68.7%
0.00%
-100.0%
Q2 2023$2,325,088
+325.4%
81,070
+255.6%
0.00%
Q1 2023$546,516
+41.3%
22,8000.0%0.00%
Q4 2022$386,688
+14.4%
22,8000.0%0.00%
Q3 2022$338,000
-17.8%
22,800
-12.6%
0.00%
Q2 2022$411,000
-41.6%
26,1000.0%0.00%
Q1 2022$704,000
-27.1%
26,1000.0%0.00%
Q4 2021$966,000
-22.5%
26,1000.0%0.00%
Q3 2021$1,247,000
+22.4%
26,100
-13.3%
0.00%
Q2 2021$1,019,000
-18.0%
30,1000.0%0.00%
-100.0%
Q1 2021$1,243,000
-4.8%
30,1000.0%0.00%0.0%
Q4 2020$1,306,000
+89.0%
30,100
+87.0%
0.00%
Q3 2020$691,000
-11.5%
16,100
-3.6%
0.00%
Q2 2020$781,00016,7000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 204,673$10,164,0006.19%
CVI Holdings, LLC 200,032$9,349,0003.47%
DAFNA Capital Management LLC 149,017$6,965,0002.01%
Cormorant Asset Management, LP 800,000$37,392,0001.43%
ARK Investment Management 1,918,835$89,686,0000.96%
EAM Global Investors LLC 30,948$1,447,0000.65%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,362,0000.61%
Monashee Investment Management LLC 79,497$3,716,0000.56%
EAM Investors, LLC 40,695$1,902,0000.42%
Diametric Capital, LP 11,478$536,0000.41%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders